Ltd. was founded in June 2002, with a registered capital of 130 million yuan, headquartered in the famous historical and cultural city of Jinan, Shandong Province, which is surrounded by lotus flowers and willows, and a city of mountains and half a city of lakes. It is a high-tech enterprise focusing on the research and development, production, sales and service of pharmaceutical APIs, intermediates and fine chemicals, and is committed to the research and development and application of new technologies in the fields of MAH, CDMO, veterinary medicine and agrochemicals, etc. The Group now has one R&D center, which is located in Jinan, Shandong Province. The group now has one R&D center-Shandong Chengchuang Blue Ocean Pharmaceutical Technology Co., Ltd, one API factory-Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. and two pharmaceutical intermediates production bases, with more than 1,000 employees, and more than 300 R&D team members.
Products
GMP
Lidocaine Hydrochloride, Lidocaine, Bupivacaine Hydrochloride, Procainamide, Celecoxib, Sugar Glucose Sodium, Ozagrel Sodium, Lacidipine, Urapidil Hydrochloride
State I
Vonorasan fumarate, Cliborol , ropivacaine hydrochloride, bupivacaine, bupivacaine hydrochloride, ativacaine hydrochloride
Reported CEP
Mildronate (approved), ropivacaine hydrochloride (under review), ativacaine hydrochloride (under review)
US-DMF
Proparacaine hydrochloride, bupivacaine, pramoxine hydrochloride, vonorasan fumarate
under development
Letemovir, rucotinib, fenelidone, marbofloxacin, abatacept, tadalafil, florentina, aflatina, sarolana, etc.
*All our products are not offered in countries where valid patents exist. All responsibility with repect to third parties patent rights in specific countries lies exclusively with the buyers.
产品明细
| Product Name |
产品名称 |
CAS |
| *Vonoprazan Fumarate |
富马酸伏诺拉生 |
1260141-27-2
881681-01-2
|
| *Letermovir |
来特莫韦 |
917389-32-3 |
| *Dapagliflozin propanediol monohydrate |
达格列净一水丙二醇 |
960404-48-2 |
| *Crisaborole |
克立硼罗 |
906673-24-3 |
| Prilocaine |
丙胺卡因 |
721-50-6 |
| Lidocaine hydrochloride |
盐酸利多卡因 |
6108-05-0 |
| Lidocaine |
利多卡因 |
137-58-6 |
| Ozagrel sodium |
奥扎格雷钠 |
189224-26-8 |
| Celecoxib |
塞来昔布 |
169590-42-5 |
| Ropivacaine hydrochloride |
盐酸罗哌卡因 |
132112-35-7 |
| Sugammadex sodium |
舒更葡糖钠 |
343306-79-6 |
| Tetracaine hydrochloride |
盐酸丁卡因 |
136-47-0 |
| Tetracaine |
丁卡因 |
94-24-6 |
| Prilocaine hydrochloride |
盐酸丙胺卡因 |
1786-81-8 |
| Pramoxine hydrochloride |
盐酸普莫卡因 |
637-58-1 |
| Meldonium |
米屈肼 |
86426-17-7 |
| Bupivacaine hydrochloride |
盐酸布比卡因 |
73360-54-0 |
| Bupivacaine |
布比卡因 |
2180-92-9 |
| Articaine hydrochloride |
盐酸阿替卡因 |
23964-57-0 |
| Tadalafil |
他达那非 |
171596-29-5 |
| *Apalutamide |
阿帕他胺 |
956104-40-8 |
| *Baloxavir Marboxil |
玛巴洛沙韦 |
1985606-14-1 |
| *Fluralaner |
氟雷拉纳 |
864731-61-3 |
| *Afoxolaner |
阿福拉纳 |
1093861-60-9 |
| *Sarolaner |
沙罗拉纳 |
1398609-39-6 |
| *Ruxolitinib |
芦可替尼 |
941678-49-5 |
| *Finerenone |
非奈利酮 |
1050477-31-0 |
| *Upadacitinib |
乌帕替尼 |
1310726-60-3 |
| Ozenoxacin |
奥泽沙星 |
245765-41-7 |
| Donepezil hydrochloride |
盐酸多奈哌齐 |
120011-70-3 |
| Levobupivacaine hydrochloride |
盐酸左布比卡因 |
27262-48-2 |
| Dibucaine hydrochloride |
盐酸地布卡因 |
CAS：61-12-1 |
| Mepivacaine hydrochloride |
盐酸甲哌卡因 |
1722-62-9 |
| Medetomidine hydrochloride |
盐酸美托咪啶 |
86347-15-1 |
| Dyclonine hydrochloride |
盐酸达克罗宁 |
536-43-6 |
| Dienogest |
地诺孕素 |
65928-58-7 |
| Altrenogest |
烯丙孕素/四烯雌酮 |
850-52-2 |
| Brexanolone |
5alpha-孕甾-3alpha-醇-20-酮 |
516-54-1 |
| Metoclopramide |
甲氧氯普胺（胃复安） |
364-62-5 |
| Brinzolamide |
布林佐胺 |
138890-62-7 |
| Terbinafine hydrochloride |
盐酸特比萘芬 |
78628-80-5 |
| Mexidole |
美昔得乐 |
127464-43-1 |
| Dexmedetomidine hydrochloride |
盐酸右美托咪定 |
145108-58-3 |
| Nadifloxacin |
那氟沙星 |
124858-35-1 |
|
富马酸伏诺拉生中间体
Vonoprazan Fumarate Intermediates
|
| 5-(2-fluorophenyl)-1H-Pyrrole-3-carboxaldehyde |
5-(2-氟苯基)-1H-吡咯-3-甲醛 |
881674-56-2 |
| Pyridine-3-sulfonyl chloride hydrochloride |
吡啶-3-磺酰氯 |
16133-25-8 |
|
达格列净中间体
Dapagliflozin Intermediates
|
| 5-bromo-2-chloro-4’-ethoxydiphenylmethane |
5-溴-2-氯-4’-乙氧基二苯甲烷 |
461432-23-5 |
| [(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]oxan-2-yl]methyl acetate |
(2R,3R,4R,5S,6S)-2-(乙酰氧基甲基)-6-(4-氯-3-(4-乙氧基苄基)苯基)四氢-2H-吡喃-3,4,5-三yl 三乙酸酯 |
461432-25-7 |
|
来特莫韦中间体
Letemovir Intermediates
|
|
2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)
-2-oxo-1,2,3,4-tetrahydroquinazolin-4-yl) acetic acid methyl ester
|
2-(8-氟-3-(2-甲氧基-5-(三氟甲基)苯基)-2-氧代-1,2,3,4-四氢喹唑啉-4-基)乙酸甲酯 |
917389-21-0 |
| 1-(3-Methoxyphenyl)Piperazine Hydrochloride |
1-(3-甲氧基苯基)哌嗪盐酸盐 |
16015-70-6 |
|
克立硼罗中间体
Crisaborole Intermediates
|
| 2-bromo-5-hydroxybenzaldehyde |
2-溴-5-羟基苯甲醛 |
2973-80-0 |
| 4-[4-bromo-3-(hydroxymethyl)phenoxy]benzonitrile |
4-[4-溴-3-(羟基甲基)苯氧基]苯甲腈 |
906673-45-8 |
| [2-bromo-5-(4-cyanophenoxy)phenyl]methyl acetate |
2-溴-5-（4-氰基苯氧基）乙酸苄酯 |
2227126-09-0 |
|
玛巴洛沙韦中间体
Baloxavir Marboxil Intermediates
|
| (R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione |
(R)-7-(苄氧基)-3,4,12,12A-四氢-1H-[1,4]噁嗪[3,4-C]吡啶并[2,1-F] [1,2,4]三嗪-6,8二酮（巴沙洛韦母核） |
1985607-70-2 |
| 3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid |
3-(苄氧基)-4-氧代-4H-吡喃-2-羧酸 |
119736-16-2 |
| 7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol |
7,8 -二氟- 6,11 -二氢-二苯并[ B,E ]噻吩并- 11 -醇 |
1985607-83-7 |
|
非奈利酮中间体
Finerenone Intermediates
|
| 4-formyl-3-methoxybenzonitrile |
4-氰基-2-甲氧基苯甲醛 |
21962-45-8 |
| 4-amino-5-methylpyridone |
4-氨基-5-甲基-2-羟基吡啶 |
95306-64-2 |
| 2-cyanoethylacetoacetate |
2-氰基乙酰乙酸乙酯 |
65193-87-5 |
| 2-chloro-5-methylpyridin-4-amine |
2-氯-4-氨基-5-甲基吡啶 |
79055-62-2 |
|
阿帕他胺中间体
Apalutamide Intermediates
|
| 5-Amino-3-(trifluoromethyl)picolinonitrile |
5-氨基-3-(三氟甲基)氰基吡啶 |
573762-62-6 |
| N-Boc-1-aminocyclobutanecarboxylic acid |
Boc-1-氨基环丁烷羧酸 |
120728-10-1 |
| 1-amino-N-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]Cyclobutanecarboxamide |
1-氨基-N-[6-氰基-5-(三氟甲基)-3-吡啶基]-环丁烷甲酰胺 |
1950587-17-3 |
|
磷酸芦可替尼中间体
Ruxolitinib Phosphate Intermediates
|
| 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
1-(1-乙氧基乙基)-4-吡唑硼酸频哪醇酯 |
1029716-44-6 |
| 3-Cyclopentylacrylonitrile |
3-环戊基丙烯腈 |
591769-05-0 |
| (4-(1-(2-Cyano-1-cyclopentylethyl)-1h-pyrazol-4-yl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
(4-(1-(2-氰基-1-环戊基乙基)-1h-吡唑-4-基)-7h-吡咯并[2,3-d]嘧啶-7-基)特戊酸甲酯 |
1236033-05-8 |
|
乌帕替尼中间体
Upadacitinib Intermediates
|
| (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester |
|
1428243-26-8 |
| tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate |
|
1201187-44-1 |
| 8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine |
|
1428243-28-0 |
|
奥泽沙星中间体
Ozenoxacin Intermediates
|
| ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate |
奥泽沙星中间体A |
103877-51-6 |
| 5-broMo-N,3-diMethylpyridin-2-aMine |
奥泽沙星中间体B |
245765-66-6 |
| [6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]boronic acid |
奥泽沙星中间体D |
446299-81-6 |
|
布林佐胺中间体
Brinzolamide Intermediates
|
| (S)-3,4-dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide |
(S)-6-氯-3,4-二氢-2H-噻吩并[3,2-e]-1,2-噻嗪-4-醇1,1-二氧化物 |
160982-16-1 |
| (S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide |
(S)-3,4-二氢-4-羟基-2-(3-甲氧基丙基)-2H-噻吩并[3,2-e]-1,2-噻嗪-6-磺胺-1,1-二氧化物 |
154127-42-1 |
|
盐酸阿替卡因中间体
Articaine hydrochloride Intermediates
|
| 3-Amino-4-methyl-2-thiophene carboxylic acid methyl ester |
3-氨基-4-甲基噻吩-2-甲酸甲酯 |
85006-31-1 |
|
盐酸罗哌卡因中间体
Ropivacaine Intermediates
|
| N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide |
|
15883-20-2 |
| (2S)-N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide |
|
27262-40-4 |
|
别孕酮中间体
Brexanolone Intermediates
|
| Allopregnan-3β-ol-20-one acetate |
别孕烯醇酮醋酸酯 |
906-83-2 |
| 3β-hydroxy-5α-pregnan-20-one |
别孕烯醇酮 |
516-55-2 |
|
氟雷拉纳中间体
Fluralaner Intermediates
|
| 4-acetyl-2-methylbenzoic acid |
2-甲基-4-乙酰基苯甲酸 |
55860-35-0 |
| 2-AMino-N-(2,2,2-trifluoroethyl)acetaMide hydrochloride |
2-氨基-N-(2,2,2-三氟乙基)乙酰胺盐酸盐 |
1171331-39-7 |
| 3',5'-DICHLORO-2,2,2-TRIFLUOROACETOPHENONE |
3', 5'-二氯-2, 2, 2-三氟苯乙酮 |
130336-16-2 |
|
阿福拉纳中间体
Afoxolaner Intermediates
|
| 4-acetyl-1-naphthoic acid |
4-乙酰基萘甲酸 |
131986-05-5 |
| 2-AMino-N-(2,2,2-trifluoroethyl)acetaMide hydrochloride |
2-氨基-N-(2,2,2-三氟乙基)乙酰胺盐酸盐 |
1171331-39-7 |
| 1-[3-Chloro-5-trifluoromethylphenyl]-2,2,2-trifluoroethanone |
1-[3-氯-5-(三氟甲基)苯基]-2,2,2-三氟乙酮 |
1125812-58-9 |
*All our products are not offered in countries where valid patents exist. All responsibility with repect to third parties patent rights in specific countries lies exclusively with the buyers.
MAH Business
Based on the existing APIs, MAH business has carried out in-depth excavation of preparation projects and formed specialized MAH routes in niche areas, and 11 MAH projects have been carried out, among which the project of Sodium Sugar Glucose has been approved, and the preparation of Lidocaine has been submitted to the State Bureau to enter the clinical research stage.
CDMO Business
We can undertake the customization and service of high-end pharmaceutical intermediates, new agrochemical intermediates, veterinary intermediates such as pet drugs, and cross-border products and intermediates in the health category.
Contact us
Shandong Chenghui Pharmaceutical Group Co.
chenghui pharmaceutical group ltd
Pharmaceutical Business
Manager Shen 0531-58897066
Manager Liao 0531-58897055
Trading company business
Mr. Li 0531-58897086
Mr. Huang 0531-58897087
Manager Tang 0531-58897051
Veterinary medicine business
Mr. Ren 0531-58897165
Marketing Department
Manager Xie 0531-58897070
Recruitment
Mr. Li 0531-58897028
Mailbox
sales@jnchsd.com
market@jnchsd.com
Official website: www.jnchsd.com
Address：No.2350, Pioneering Road, Gaoxin District, Jinan City, Shandong Province, China.
ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
![methyl[(1S)-1-(pyridin-4-yl)ethyl]amine](https://eimg.pharmasources.com/image/product/20240718/3d5490e25591040c9aecf0548fceab4djpg)
![sodium(R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimid](https://eimg.pharmasources.com/img_Cphi_en/Product/2017_07/Mimg_1707170459888179.jpg)
Pharma Sources Insight June 2024: Globalization on the Go
